Mellinghoff IK, Vivanco I, Kwon A, Tran C, Wongvipat J, Sawyers CL
On the Klarity Health platform, find a dedicated healthcare provider ready to help tailor a weight loss plan for your unique needs
It's shaping people's perceptions about weight loss, transforming attitudes towards obesity treatments, and most importantly, it's driving demand
ECRI members may access this report in its entirety here
Mounjaro also targets GIP receptors, which play a role in how your body handles sugar and fat
Initially developed for type 2 diabetes management, GLP-1 agonists effectively promote weight loss in preclinical and clinical studies [11] [12], leading to their investigation and subsequent approval for obesity treatment in non-diabetic patients